Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Oxazolidinone; protein synthesis inhibitor.
ACE inhibitor.
Dipeptide; aminopeptidase (N/CD13) inhibitor.
Benzimidazole; microtubule polymerization inhib...
PKMYT1 inhibitor
Peptide, derivative of AT I, cleavage product o...
5-HT7 and D2/3 antagonist.
Endogenous secondary bile acid.
Flavone found in Teucrium.
Polyphenolic compound present in black tea.
5-FU prodrug; thymidylate synthase inhibitor.
STING inhibitor
Aza-anthracenedione, DNA intercalator; topoisom...
Cephalomannine derivative found in Taxus; poten...
c-MET, Tie-2, VEGFR inhibitor.
Thienylbutyl ITC analog.
Thiazole; proteasome inhibitor, protein translo...
SIRT inhibitor.
DNA alkylator.
Bulgarialactone azaphilone